Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Jan 2025.
- Notable investors include Benchstrength (New York), Analog Ventures, January Ventures, Thomas Lee.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Systole
- ·The full record, as it builds
Funding rounds
No funding rounds for Systole are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Systole
Provider of comprehensive virtual care services intended to support women's heart health through personalized, proactive plans. The company's platform combines medical care, lifestyle guidance, educational resources, peer support, personalized coaching, and emotional support, enabling busy women to prioritize their heart health without disrupting their schedules.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2023
- Employees
- 7
- Website
- systolehealth.com/
- Ownership
- Privately Held (backing)
Systole doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Systole shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Systole in its N-PORT filings yet. We sweep new filings monthly.